Survival Outcomes of Patients with Primary Breast Cancer Following Primary Ovarian Cancer

被引:5
|
作者
Zhang, Wei [1 ]
Zhang, Wenque [1 ]
Lin, Zhihong [1 ]
Wang, Fang [1 ]
Li, Miaojie [1 ]
Zhu, Libo [2 ]
Yu, Yixian [3 ]
Gao, Yutao [3 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 6, Peoples Hosp Yuxi City, Dept Gynaecol, Yuxi, Yunnan, Peoples R China
[2] Dali Bai Autonomous Prefecture Peoples Hosp, Dept Gastroenterol, Dali, Yunnan, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 1, Dept Gynecol, Kunming, Yunnan, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2019年 / 25卷
关键词
Ovarian Neoplasms; SEER Program; Triple Negative Breast Neoplasms; MUTATION CARRIERS; RISK; WOMEN; BRCA1; STATISTICS; PATTERNS;
D O I
10.12659/MSM.914163
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Patients with primary breast cancer following primary ovarian cancer do not comprise a large clinical entity, and reports of the survival outcomes of this cohort are rare. The purpose of this retrospective population-based research was to investigate the survival outcomes of patients with primary breast cancer after primary ovarian cancer. Material/Methods: A cohort of patients diagnosed with primary breast cancer following primary ovarian cancer between 1973 and 2014 was drawn from the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database. Cox proportional hazards survival regression analysis and Kaplan-Meier were applied to calculate overall survival (OS), cancer-specific survival (CSS), and independent predictors of CSS. Results: A total of 1455 patients with primary breast cancer following primary ovarian cancer were identified. The 5-year and 10-year OS rates for the entire cohort were 81.7% and 67.4%, respectively. The 5-year and 10-year CSS rates were 84.2% and 74.3% for ovarian cancer, and 76.0% and 67.8% for breast cancer, respectively. Multivariate analysis revealed that independent predictors of ovarian cancer CSS include age, cancer stage, diagnosis time, and histological subtype. Conclusions: Patients diagnosed with breast cancer following ovarian cancer have better survival rates. Patients age, ovarian cancer stage, ovarian cancer histological type, and time of diagnose affect the survival rate.
引用
收藏
页码:3869 / 3879
页数:11
相关论文
共 50 条
  • [1] Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
    Chen, Chang
    Xu, Yali
    Huang, Xin
    Mao, Feng
    Shen, Songjie
    Xu, Ying
    Sun, Qiang
    MEDICINE, 2020, 99 (32) : E21560
  • [2] Declining Second Primary Ovarian Cancer After First Primary Breast Cancer
    Schonfeld, Sara J.
    de Gonzalez, Amy Berrington
    Visvanathan, Kala
    Pfeiffer, Ruth M.
    Anderson, William F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 738 - 743
  • [3] Pathological confirmation of primary lung cancer following breast cancer
    Tennis, M.
    Singh, B.
    Hjerpe, A.
    Prochazka, M.
    Czene, K.
    Hall, P.
    Shields, P. G.
    LUNG CANCER, 2010, 69 (01) : 40 - 45
  • [4] Development of a Second Primary Lung Cancer Following a Primary Breast Cancer: A Case Series
    Sua, Luz F.
    Osorio, Alvaro E.
    Zuniga-Restrepo, Valeria
    Ibarra, Ciro D.
    Quintero, Natalia
    Fernandez-Trujillo, Liliana
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2024, 12
  • [5] Surgical Outcome and Survival Analysis of Young Patients with Primary Epithelial Ovarian Cancer
    Fotopoulou, Christina
    Savvatis, Konstantinos
    Schumacher, Guido
    Lichtenegger, Werner
    Sehouli, Jalid
    ANTICANCER RESEARCH, 2009, 29 (07) : 2809 - 2815
  • [6] Diagnostic challenge and survival analysis of pulmonary oligometastases and primary lung cancer in breast cancer patients
    Mai, Siyao
    Liu, Haiqing
    Zeng, Hong
    Cheng, Ziliang
    Huang, Jingwen
    Shi, Guangzi
    Li, Yong
    Wu, Zhuo
    THORACIC CANCER, 2024, 15 (12) : 1017 - 1028
  • [7] Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
    Lee, Janghee
    Park, Seho
    Kim, Sanghwa
    Kim, Jeeye
    Ryu, Jegyu
    Park, Hyung Seok
    Kim, Seung Il
    Park, Byeong-Woo
    YONSEI MEDICAL JOURNAL, 2015, 56 (05) : 1213 - 1220
  • [8] Survival analysis of patients with unilateral and bilateral primary breast cancer in Northeast China
    Xing, Ying
    Meng, Qingwei
    Sun, Lichun
    Chen, Xuesong
    Cai, Li
    BREAST CANCER, 2015, 22 (05) : 536 - 543
  • [9] Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study
    Wang, Kevin Yu
    Lee, Chung-Shien
    Vempati, Prashant
    Sharma, Rajiv
    Kohn, Nina
    Seetharamu, Nagashree
    CLINICAL LUNG CANCER, 2023, 24 (06) : E198 - E204
  • [10] Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
    Escala-Garcia, Maria
    Canisius, Sander
    Keeman, Renske
    Beesley, Jonathan
    Anton-Culver, Hoda
    Arndt, Volker
    Augustinsson, Annelie
    Becher, Heiko
    Beckmann, Matthias W.
    Behrens, Sabine
    Bermisheva, Marina
    Bojesen, Stig E.
    Bolla, Manjeet K.
    Brenner, Hermann
    Canzian, Federico
    Castelao, Jose E.
    Chang-Claude, Jenny
    Chanock, Stephen J.
    Couch, Fergus J.
    Czene, Kamila
    Daly, Mary B.
    Dennis, Joe
    Devilee, Peter
    Dork, Thilo
    Dunning, Alison M.
    Easton, Douglas F.
    Ekici, Arif B.
    Eliassen, A. Heather
    Fasching, Peter A.
    Flyger, Henrik
    Gago-Dominguez, Manuela
    Garcia-Closas, Montserrat
    Garcia-Saenz, Jose A.
    Geisler, Juergen
    Giles, Graham G.
    Grip, Mervi
    Guendert, Melanie
    Hahnen, Eric
    Haiman, Christopher A.
    Hakansson, Niclas
    Hall, Per
    Hamann, Ute
    Hartikainen, Jaana M.
    Heemskerk-Gerritsen, Bernadette A. M.
    Hollestelle, Antoinette
    Hoppe, Reiner
    Hopper, John L.
    Hunter, David J.
    Jacot, William
    Jakubowska, Anna
    SCIENTIFIC REPORTS, 2021, 11 (01)